Metabolic Disorders in Chronic Lung Diseases

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Metabolic Disorders in Chronic Lung Diseases

Chronic lung diseases represent complex diseases with gradually increasing incidence, characterized by significant medical and financial burden for both patients and relatives. Their increasing incidence and complexity render a comprehensive, multidisciplinary, and personalized approach critically important. This approach includes the assessment of comorbid conditions including metabolic dysfun...

متن کامل

The Relationship between Metabolic Disorders and Helminth Diseases

Les auteurs passent en revu les perturbations du metabolisme general et particulier et en tirent les consequences d'ordre pathologique et therapeutique. 

متن کامل

Vascular Diseases and Metabolic Disorders

Vascular diseases include cardiovascular and peripheral vascular diseases. For decades, cardiovascular diseases (CVD) stay the number one mortality worldwide. In more details, coronary heart disease or stroke alone caused around 1 of every 6 deaths or 1 of every 19 deaths in the United States in 2010, respectively [1]. The total direct and indirect cost of CVD remains higher than any other diag...

متن کامل

Chronic Kidney Diseases, Metabolic Syndrome and Crp Level in The Elderly Residents of Kahrizak Charity Foundation

Objectives: In this study, we investigated the inter-relationships between C-reactive protein, metabolic syndrome, and chronic kidney disease among a group of Iranian elderly. Methods & Materials: In this cross-sectional study, 122 elderly among 1220 aged residents of Kahrizak Charity foundation with average age of 73.6±9.71 were studied. Metabolic syndrome and chronic kidney diseasewere def...

متن کامل

Effect of Zafirlukast on improving lung function in patients with chronic obstructive pulmonary diseases

  Background : There is little evidence about the role of Zafirlukast (a highly selective LTD4 antagonist) in Chronic Obstructive Pulmonary Disease (COPD). The Zafirlukast can reduce the need for short-acting rescue β2 agonists, produce fewer exacerbations of asthma and increased quality of life as possible benefits treatment for asthma. The aim of our study was to evaluate the effects of Zafir...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Frontiers in Medicine

سال: 2018

ISSN: 2296-858X

DOI: 10.3389/fmed.2017.00246